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ABSTRACT 
Electrospinning technique is a versatile method to fabricate continuous fibers with 
diameters ranging from a few micrometers to a few nanometers. In this study, chitosan/ poly 
(vinyl alcohol) (PVA) nanofibers were fabricated by an electrospinning method. The effects of 
chitosan molecular weights and ratio of chitosan/PVA were studied. The characteristics and 
surface morphologies of nanofibers were observed by the Scanning Electron Microscope (SEM). 
The diameters of nanofibers were in the range of 100 nm to 250 nm. The chitosan/PVA 
nanofibers with different molecular weights were applied for curcumin delivery. Curcumin was 
loaded in the chitosan/PVA nanofibers. Then, release profile of curcumin was investigated. In 
the results, the encapsulation efficiency and the release rate demonstrate that chitosan/PVA 
nanofibers would be potential carriers for curcumin and promise to create a prospective drug 
delivery in the field of medicine. 
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1. INTRODUCTION 
Electrospinning is a simple and versatile method for creating nanofibers [1]. The 
electrospinning has many advantages such as low cost, high production rate [2]. Electrospun 
nanofibers have a high surface-to-volume area. Thus, electrospun nanofibers have been applied 
for filtration, reinforcement in composite material, tissue engineering, energy-related 
applications, environmental applications, and especially in drug delivery [2 - 6]. 
Chitosan, poly-β-(1→4)-D-glucosamine, is a partially deacetylated chitin by concentrated 
alkaline [7 - 12]. The number of N-acetyl-glucosamine units is higher than 50 % [13, 14]. The 
amino groups of chitosan can be positively charge in dilute acid medium (pKa 6.3, pH < 6) to 
become fully soluble [7, 13]. Chitosan is an attractive material for use in drug delivery due to 
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controlled biodegradability and biocompatibility [7, 8, 15 – 17]. In previous studies, several 
solvents used in the electrospinning of chitosan are diluted hydrochloric acid, acetic acid, and 
neat formic acid [6, 7]. However, only TFA can successfully produce chitosan nanofibers with 
the best homogeneity [7]. TFA can destroy the rigid electrostatic interactions between the 
chitosan molecular chains and the high volatility of TFA can enhance the rapid solidification of 
chitosan fibers. With other acids, the formation of protonation with amino groups causes serious 
repulsion forces under a high applied voltage in electrospinning, resulting in the instability of 
electrospun fibers. So, conditions of chitosan electrospinning are often controlled very precisely 
due to the positive groups of chitosan, which repulse each other during electrospinning process. 
Moreover, the viscosity of chitosan solutions is very high. Thus, chitosan blended with 
electrospunable polymers, such as PVA enable the fabrication of homogeneous CS nanofibers 
[18 – 20]. 
Curcumin, a natural polyphenolic phytochemical extracted from the rhizomes of turmeric 
(Curcuma longa L.), has attracted considerable attention in recent years due to its great variety of 
beneficial biological and pharmacological activities including anti-inflammatory, anti-cancer, 
anti-oxidant, wound healing  and anti-microbial effects [21 – 23]. However, widespread clinical 
application of this relatively efficacious agent in cancer and other diseases has been limited due 
to poor aqueous solubility, and consequently, minimal systemic bioavailability [24]. Attempts to 
improve water solubility, stability, and bioavailability of curcumin by complex formation or 
interaction with macromolecules including gelatins, polysaccharides and phospholipids were 
previously reported [25]. However, toxic organic solvents were still used in these procedures. 
Recently, nanoparticle technology has emerged as a potential area of targeted drug delivery 
systems and made biologically availability of therapeutic agent. Nanoparticles are easier to pass 
through cell membranes in organisms and get interacted rapidly with biological systems. The 
development of effective approaches to improve the aqueous solubility and bioavailability of 
curcumin is therefore necessary. Therefore curcumin compound is incorporated into chitosan-
PVA nanofibers to improve significantly the therapeutic efficacy of the fiber film [24, 26 – 28]. 
In this study, chitosan/PVA nanofibers were fabricated by electrospinning method. The 
effects of chitosan molecular weights as well as ratio of chitosan/PVA were investigated.  The 
nanofibers were also applied for curcumin release. The encapsulation efficiency and release 
profiles were established. 
2. MATERIALS AND METHODS 
2.1. Materials 
Chitosan, acetic acid (glacial, 99 - 100 %), ethanol, PVA (146-186 kDa of molecular 
weight with the degree of acetylation, 87 - 89 %), hydrogen peroxide, hydrochloric acid, sodium 
hydroxide, and phosphate buffered saline (PBS) were purchased from Sigma-Aldrich. Curcumin 
(CUR) was obtained from Viet Nam Institute of Dietary Supplements (Viet Nam).  
2.2. Chitosan degradation and determination of molecular weight (Mv) 
Depolymerization of chitosan using hydrogen peroxide has been described in the previous 
research. Chitosan (3 g, 300 kDa) was dissolved in 200 ml of a 0.5 % HCl acid solution. The 
solution was added 2 ml of 30 % H2O2, and reacted at 40 oC for 2, 4, and 8 h before it was 
filtrated and adjusted to pH 9-10 by using NaOH. The chitosan became immiscible after 
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increasing pH and was suspended in the aqueous solution. Then, the deposited chitosan was 
rinsed with deionized water. 
The viscosity- average molecular weight of chitosan (Mv) was determined by the Mark- 
Houwink equation: 
[η] = 1.81×10-3 (cm3.g-1). 93.0vM  (1)
where the intrinsic viscosity [η] of a chitosan solution was measured by the Ubbelohde capillary 
viscometer at 25 oC in triplicate. After that, the viscosity- average molecular weight of chitosan 
was determined by the regression of Mark- Houwink equation. The results indicate that different 
molecular weights (100 kDa, 150 kDa, and 200 kDa) of chitosan were obtained. 
2.3. Electropsinning of chitosan/PVA  
PVA were dissolved in distilled water to prepare a PVA solution of 8 g.L-1.  After stirring 
for 6 hours at 60 °C, the PVA solution was obtained. Chitosan with various molecular weights 
was dissolved in 2 % (v/v) of acetic acid to form a chitosan solution of 2 g.L-1 by stirring for 8 
hours, at room temperature. Both the polymer solutions were mixed with various weight ratios 
of chitosan/PVA at room temperature, yielding the homogeneous chitosan/PVA solutions. 
The polymer solutions were placed into a syringe. The feeding rate of solution was 
controlled by a syringe pump (Cole Palmer, Model 74900, USA) at 0.5 mL.h-1. The tip-to-
collector distance was 10 cm and the applied voltage was 15 kV. The experiments were 
performed in air at room temperature.  
2.4. Characterization of nanofibers 
The morphology of the electrospinning fibers was observed on a Scanning Electron 
Microscope (SEM, JSM 5500, JEOL, Japan).  Samples for SEM were dried at 37 oC. A small 
section of the fiber mat was placed on the SEM sample holder and sputter-coated with gold for 
60 second with an accelerating voltage of 10 kV. The average diameter and the distribution of 
electrospun fiber were obtained by analyzing the SEM images with an ImageJ software. 
2.5. Determination of encapsulation efficiency and loading capacity of curcumin 
Curcumin was dissolve in ethanol to form the solution of 5 % wt. 30 mg chitosan/PVA 
nanofibers was immerged in 30 mL curcumin solution. After 24 hours, the solution was 
analyzed for total curcumin content by a UV spectrophotometer at 425 nm. Curcumin loading 
capacity (LC) and encapsulation efficiency (EE) were calculated by the following equations.  
Amount of curcumin in the nanofibersLC= ×100
Amount of the nanofibers
 (1) 
 
Amount of curcumin in the nanofibersEE= ×100
Amount of initial curcumin .
 (2) 
 
2.6. In vitro release of curcumin 
Chitosan-curcumin nanofibers (20 mg) were incubated in 50 mL PBS at pH 7.4 and 37 oC 
with shaking (120 rpm). At a given time, the sample was centrifuged. Then, 8 mL of the solution 
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was taken out for analysis and 8 mL of fresh PBS was added into the releasing bath. Curcumin 
amount was measured by a UV spectrophotometer at 425 nm.  Each experiment was performed 
in triplicate and the results report mean value ± standard deviation. 
3. RESULTS AND DISCUSSION 
3.1. Effect of chitosan molecular weight 
 
Figure 1. SEM images of chitosan/PVA nanofibers with various chitosan molecular weights:                                    
(A) 100 kDa; (B) 150 kDa; (C) 200 kDa; (D) 300 KDa. 
The morphology and diameter of electrospun nanofibers depend on the various parameters. 
Among these parameters, the chitosan molecular weight of the electrospinning solution was one 
of the most effective variables to control the fiber morphology and diameter. To study the effect 
of chitosan molecular weight, the others main electrospinning parameters were fixed as 2 % of 
acetic acid concentration, 15 kV of applied voltage and 0.5 mL.h-1 of flow rate.  
Figure 1 shows the SEM images with CS molecular weights range from 300 to 100 kDa. 
An increase in the chitosan molecular weight from 100 kDa to 300 kDa, the morphology of 
electrospun nanofibers was changed. At 100 kDa and 300 kDa, chitosan/PVA nanofibers and 
large beads were obtained (Fig. 1a and 1d). In contrast, only chitosan/PVA nanofibers were 
obtained with the chitosan molecular weight of 200, and 150 kDa as shown in Fig. 1b and 1c. 
The results revealed that chitosan with medium molecular weight were advantageous to form 
continuous nanofibers due to the low viscosity of solution. It was due to the strong entanglement 
force in the polymer chains which is indicated by the high viscosity of the solution. The high 
molecular weight, which indicates the longer polymer chains, results in a higher degree of 
entanglement between polymer chains. With low molecular weight, the entanglement forces 
were not enough to keep the continuous fibers. Thus, chitosan with 150 kDa and 200 kDa were 
proper for electrospinning. 
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3.2. Effect of ratio of CS/PVA 
 
Figure 2. Effect of ratio of PVA/chitosan with chitosan molecular weight of 150 kDa: (A) 1/3.6;                           
(B) 1/3.2; (C) 1/3; (D) 1/2.8. 
Conditions of chitosan electrospinning are often controlled very precisely due to the 
positive groups of chitosan, which repulse each other during electrospinning process. Moreover, 
the viscosity of chitosan solutions is very high. Thus, chitosan blended with PVA enable the 
fabrication of homogeneous chitosan nanofibers. 
Figure 2 shows the SEM images of chitosan/PVA nanofibers with various ratio of 
PVA/chitosan with chitosan molecular weight of 150 kDa. An increase in ration of PVA/chitosan, 
the morphology of electrospun nanofibers was changed. With the ratio of PVA/chitosan higher than 
1/3 (Figure 2c and 2d), the uniform nanofibers were obtained, where the average diameter was about 
200 nm. It can be explain because the PVA adding could decrease the viscosity of polymer solutions 
as well as destroyed the rigid structure of chitosan. However, chitosan has several outstanding 
properties that can apply for drug delivery in compare with PVA. Thus, the higher ratio of 
chitosan/PVA was proper for fabrication of electrospun nanofibers. Thus, the ratio of PVA/chitosan 
was chosen for further experiment was 1/3.  
3.3. Encapsulation efficiencies and loading capacities of curcumin 
Encapsulation efficiencies (EE) and loading capacities (LC) of curcumin, determined by 
equations (1) and (2), are shown in Table 1. EE and LC decreased slightly decreased increasing 
CS molecular weight. Compared with previous studies of curcumin adsorption from chitosan 
nanoparticle, EE prepared by an electrospun technique of our study was higher [29-31]. Thus, 
chitosan/PVA nanofibers were efficiently adsorption curcumin. 
Table 1. EE and LC of curcumin on chitosan/PVA nanofibers with different molecular weights. 
Mv (kDa) EE (%) LC (%) 
150 79.67 ± 1.105 4.76 ± 0.041 
200 76.45 ± 1.234 4.63 ± 0.035 
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3.4. Curcumin release in vitro experiment 
 
Figure 3. In vitro release profiles of curcumin from different molecular weights of chitosan:                       
(a) 150 kDa, (b) 200 kDa. 
The drug release profiles are shown in Figure 1. After 148 hours, 79.5 % and 65.4 % of 
loaded curcumin was released from the nanofibers of 150-kDa chitosan and 200-kDa chitosan, 
respectively. The overall release can be divided into two stages: a rapid release in the first 20 
hours and a slow release after 20 hours. In the initial release within the first 20 hours, the 
releasing percentage of curcumin reached 56.4 % for 150-kDa chitosan and 51.2 % for 200-kDa 
chitosan. In this stage, drug presented on the nanofibers surfaces was released, and thus release 
rate mainly depended on curcumin desorption. After 20 hours, releasing rate became slow and 
was almost constant up to 148 hours (zero-order kinetics of drug release). The release rate of this 
step mainly depended on the interaction between curcumin and chitosan nanofibers. The release 
rate of curcumin from 150-kDa-CS nanofibers was somewhat higher than that from 200-kDa-CS 
nanofibers. The higher viscosity of the high molecular weight CS will form a gel layer and it 
covers the curcumin. This layer hinders the curcumin release. 
4. CONCLUSION 
Chitosan/PVA nanofibers were successful prepared by an electrospinning method. The 
chitosan molecular weights and ratio of chitosan/PVA were strong effects on the morphology of 
electrospun nanofibers. 150-kDa-chitosan and 200-kDa-chitosan molecular weights were proper 
for electrospinning. Ratio of chitosan/PVA, smaller than 1/3, could create uniform nanofibers. 
The average diameter of nanofibers was 200 nm. The adsorption efficiency and release of 
curcumin from chitosan with 150-kDa chitosan were better than that of 200-kDa chitosan. The 
release time of curcumin was prolonging until 148 hours. 
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